Our aim was to evaluate the expression of chemokines in breast cancers before treatment to identify a molecular signature that could distinguish between women with or without cancer. We identified a p
aClassification of band intensity: -, completely invisible; ±, faintly visible; +, visible; ++, clearly visible; +++, strongly visible.bmiR-126 expression was measured with TaqMan and calculated by th
Thrombospondin 1 and thrombospondin 2 (THBS1 and THBS2) share similar multifunctional domains, and are known to be antiangiogenic. However, the expression pattern of THBS1 and THBS2 is different, and
